Min Hee Hur
Impact in
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
Papers in
- Oncology 16
- Global Cancer Incidence and Screening 6
- Cancer Risks and Factors 5
- Cancer survivorship and care 4
- Cancer Cells and Metastasis 3
-
- Breast Cancer Treatment Studies 9
- Co-authors
- Max S. Wicha (2 shared papers)Suling Liu (1 shared paper)Christophe Ginestier (2 shared papers)Celina G. Kleer (1 shared paper)Julie Dutcher (2 shared papers)Patrice Viens (1 shared paper)Jocelyne Jacquemier (1 shared paper)Gabriela Dontu (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Nursing (2 papers)Medicine (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- South KoreaUnited StatesSwitzerland
In The Last Decade
Min Hee Hur
42 papers receiving 3.8k citations
Min Hee Hur's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.4k
- Cancer Research 1.2k
- Molecular Biology 1.6k
- Biotechnology 153
- Cell Biology 200
Countries citing papers authored by Min Hee Hur
This map shows the geographic impact of Min Hee Hur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Hee Hur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Hee Hur more than expected).
Fields of papers citing papers by Min Hee Hur
This network shows the impact of papers produced by Min Hee Hur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Hee Hur. The network helps show where Min Hee Hur may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Hee Hur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome Hit paper breakdown → | 2007 | 3128 |
| 2 | 2002 | 118 | |
| 3 | 2014 | 111 | |
| 4 | 2017 | 89 | |
| 5 | 2016 | 55 | |
| 6 | 2015 | 45 | |
| 7 | 2018 | 34 | |
| 8 | 2015 | 34 | |
| 9 | 1998 | 33 | |
| 10 | 2006 | 33 | |
| 11 | 1996 | 21 | |
| 12 | 2003 | 20 | |
| 13 | 2017 | 18 | |
| 14 | 2014 | 17 | |
| 15 | 2018 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2014 | 11 | |
| 19 | 2018 | 11 | |
| 20 | 2020 | 9 |
About Min Hee Hur
Min Hee Hur is a scholar working on Oncology, Cancer Research, Surgery, Pathology and Forensic Medicine and Molecular Biology, having authored 45 papers that have together received 3.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Global Cancer Incidence and Screening (6 papers), Cancer Risks and Factors (5 papers), Cancer survivorship and care (4 papers), Breast Implant and Reconstruction (4 papers), Cancer Cells and Metastasis (3 papers), Breast Lesions and Carcinomas (3 papers) and Cancer and Skin Lesions (3 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.2k citations), Molecular Biology (1.6k citations), Biotechnology (153 citations) and Cell Biology (200 citations). Min Hee Hur has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Max S. Wicha, Suling Liu, Christophe Ginestier, Celina G. Kleer, Julie Dutcher, Patrice Viens, Jocelyne Jacquemier, Gabriela Dontu, Daniel Birnbaum and Daniel Hayes. Their work appears in journals such as Journal of Clinical Oncology, Cancer Nursing, Medicine, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.